You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NUC-3373

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

Recruiting
  • Colorectal Cancer
  • +4 more
  • NUC-3373 + leucovorin
  • +8 more
  • Boston, Massachusetts
  • +9 more
Jan 23, 2023

Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,

Recruiting
  • Colorectal Cancer
  • +4 more
  • Fosifloxuridine Nafalbenamide
  • +4 more
  • Wichita, Kansas
  • +5 more
Jan 9, 2023

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Advanced Cancer, Lymphoma, Solid Tumor Trial in Edinburgh, Newcastle, Oxford (NUC-7738)

Recruiting
  • Advanced Cancer
  • +2 more
  • Edinburgh, United Kingdom
  • +2 more
Dec 7, 2022

Biliary Tract Cancer Trial in Worldwide (NUC-1031, Gemcitabine, Cisplatin)

Terminated
  • Biliary Tract Cancer
  • Tucson, Arizona
  • +124 more
Mar 16, 2022

Chronic Hepatitis B Trial in Beijing (TCR-T)

Active, not recruiting
  • Chronic Hepatitis B
  • TCR-T
  • Beijing, China
    The Fifth Medical Center of PLA General Hospital
Jun 13, 2023

Hepatitis B, Chronic Trial in Worldwide (administration of SLGN in arm C, Discontinuation of NUC treatment in arms B and C)

Recruiting
  • Hepatitis B, Chronic
  • administration of SLGN in arm C
  • Discontinuation of NUC treatment in arms B and C
  • Lyon, France
  • +7 more
Mar 11, 2022

Chronic Hepatitis B Trial in Hong Kong, Korea, Republic of (Inarigivir Soproxil, TAF)

Terminated
Has Results
  • Chronic Hepatitis B
  • Inarigivir Soproxil
  • TAF
  • Hong Kong, Hong Kong
  • +12 more
Mar 8, 2022

Chronic Hepatitis b Trial in Taiwan (Nuc Discontinuation, Entecavir or Tenofovir)

Active, not recruiting
  • Chronic Hepatitis b
  • Nuc Discontinuation
  • Entecavir or Tenofovir
  • Chiayi City, Taiwan
  • +5 more
Mar 30, 2023

Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-3373, Placebo for ABBV-3373, Adalimumab)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Huntsville, Alabama
  • +29 more
Jun 29, 2021

Hepatitis B, Chronic Trial in Worldwide (Midazolam, Placebo, RO7049389)

Completed
  • Hepatitis B, Chronic
  • Herston, Queensland, Australia
  • +20 more
Jul 7, 2022

Chronic HBV Infection Trial in Canada, United States (EDP-514, Placebo)

Completed
  • Chronic HBV Infection
  • Coronado, California
  • +14 more
Jan 6, 2022

Ovarian Cancer Trial in United Kingdom, United States (NUC-1031 500 mg, NUC-1031 750mg)

Terminated
Has Results
  • Ovarian Cancer
  • NUC-1031 500 mg
  • NUC-1031 750mg
  • Phoenix, Arizona
  • +16 more
Feb 16, 2021

HIV-1-infection Trial in San Francisco (Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch)

Completed
  • HIV-1-infection
  • Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch
  • San Francisco, California
    SFOMG Private Practice
Jan 27, 2022

Recurrent Ovarian Cancer Trial in London (Nuc-1031 and Carboplatin)

Completed
  • Recurrent Ovarian Cancer
  • Nuc-1031 and Carboplatin
  • London, United Kingdom
    Garry Weston Cancer Centre, Hammersmith Hospital
May 17, 2021

Chronic Hepatitis B Trial in Canada, New Zealand, United States (ABI-H0731, SOC NUC, Placebo Oral Tablet)

Completed
Has Results
  • Chronic Hepatitis B
  • Beverly Hills, California
  • +20 more
Jan 29, 2021

Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

Recruiting
  • Chronic Hepatitis C
  • Chronic Hepatitis B
  • Tenofovir Alafenamide 25 MG
  • Sofosbuvir / Velpatasvir
  • Beijing, Beijing, China
    Peking University First Hospital
Aug 2, 2021

Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB China

Completed
  • Chronic Hepatitis B
    • Beijing, Beijing, China
    • +54 more
    Jul 13, 2020

    HCC Patients After Curative Treatment With Low HBV Viral Load Trial in Kaohsiung, Taipei (Vemlidy® (Tenofovir Alafenamide; TAF),

    Recruiting
    • HCC Patients After Curative Treatment With Low HBV Viral Load
    • Vemlidy® (Tenofovir Alafenamide; TAF)
    • Placebo
    • Kaohsiung, State..., Taiwan
    • +3 more
    Jul 5, 2021

    Prostate Cancer Trial in New York (89ZR-DF-IAB2M, 68Ga-PSMA-HBED-CC)

    Completed
    Has Results
    • Prostate Cancer
    • New York, New York
      Weill Cornell Medicine
    Sep 18, 2020

    Chronic Hepatitis B (HBeAg-negative) Trial (Pegylated interferon alfa-2a)

    Completed
    • Chronic Hepatitis B (HBeAg-negative)
    • Pegylated interferon alfa-2a
    • (no location specified)
    Sep 4, 2019

    Pancreatic Acinar Carcinoma, Pancreatic Tumors Trial in Liverpool (Acelarin, Gemcitabine)

    Suspended
    • Pancreatic Acinar Carcinoma
    • Pancreatic Neoplasms
    • Liverpool, Merseyside, United Kingdom
      Cancer Research UK Liverpool Cancer Trials Unit
    Oct 27, 2019

    Chronic Hepatitis b Trial in Seoul (Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate)

    Completed
    • Chronic Hepatitis b
    • Tenofovir Alafenamide
    • Tenofovir Disoproxil Fumarate
    • Seoul, Korea, Republic of
      Asan Medical Center
    Mar 25, 2021

    Hepatitis B, HBV, Hepatitis B, Chronic Trial in Canada, United Kingdom (Inarigivir soproxil, Nucleoside/nucleotide (NUC)

    Terminated
    • Hepatitis B
    • +2 more
    • Inarigivir soproxil
    • Nucleoside/nucleotide (NUC) analogue inhibitors
    • Calgary, Alberta, Canada
    • +6 more
    Jul 20, 2020

    Hepatitis B, Fibrosis and Cirrhosis of Liver Trial in Kaohsiung (Tenofovir Alafenamide)

    Unknown status
    • Hepatitis B
    • Fibrosis and Cirrhosis of Liver
    • Tenofovir Alafenamide
    • Kaohsiung, Taiwan
      Kaohsiung Medical University Hospital
    Apr 24, 2019